Skip to main content

Advertisement

SpringerLink
Log in

Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases

  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Human immunodeficiency virus (HIV) dementia (HIVD) is associated with an increase in the number of activated monocytes within the central nervous system (CNS), a pathological feature that may be more remarkable in the setting of superimposed substance abuse. Monocytes may transport HIV to the brain, and, moreover, activated and/or infected monocytes have been shown to release a number of potent neurotoxins. Although the mechanisms responsible for the increase in the CNS ingress of monocytes are multiple, blood-brain barrier (BBB)-degrading matrix metalloproteinases (MMPs) are likely to play an important role. The current study investigates the effects of the HIV-1—encoded protein Tat, and the drug of abuse methamphetamine, on MMP release from brain derived cells. The release of urokinase plasminogen activator (uPA), an activator of MMPs, was also investigated. Mixed human neuron/astrocyte cultures were stimulated with Tat or methamphetamine, and supernatants were analyzed by enzyme-linked immunosorbent assay (ELISA) and/or gelatin substrate zymography. Results showed that Tat and methamphetamine increased the release of MMP-1 from these cultures. Tat also increased supernatant levels of active MMP-2. In addition, both Tat and methamphetamine stimulated the release of the MMP activator uPA, and in a manner that was sensitive to inhibition with pertussis toxin. Together, these results suggest that in HIVD, Tat and methamphetamine may contribute to CNS inflammation by stimulating increased release and/or activation of matrix-degrading proteinases through mechanisms that include Gi/Go-coupled signaling. These results also suggest a potential mechanism for acceleration of HIVD with methamphetamine use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albini A, Ferrini S, Benelli R, Sforzini S, Giunciuglio D, Aluigi MG, Proudfoot AE, Alouani S, Wells TN, Mariani G, Rabin RL, Farber JM, Noonan DM (1998). HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci U S A 95: 13153–13158.

    Article  PubMed  CAS  Google Scholar 

  • Andrews NC, Faller DV (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499.

    Article  PubMed  CAS  Google Scholar 

  • Anthony DC, Miller KM, Fearn S, Townsend MJ, Opdenakker G, Wells GM, Clements JM, Chandler S, Gearing AJ, Perry VH (1998). Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol 87: 62–72.

    Article  PubMed  CAS  Google Scholar 

  • Barchowsky A, Frleta D, Vincenti MP (2000). Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 12: 1469–1479.

    Article  PubMed  CAS  Google Scholar 

  • Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, Schettini G (2001). HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 288: 301–308.

    Article  PubMed  CAS  Google Scholar 

  • Bond M, Baker AH, Newby AC (1999). Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochem Biophys Res Commun 264: 561–567.

    Article  PubMed  CAS  Google Scholar 

  • Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85: 683–693.

    Article  PubMed  CAS  Google Scholar 

  • Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F, Collen D (1997). Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 17: 439–444.

    Article  PubMed  CAS  Google Scholar 

  • Catterall JB, Carrere S, Koshy PJ, Degnan BA, Shingleton WD, Brinckerhoff CE, Rutter J, Cawston TE, Rowan AD (2001). Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 44: 2296–2310.

    Article  PubMed  CAS  Google Scholar 

  • Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM (2002). A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology 59: 1568–1573.

    PubMed  CAS  Google Scholar 

  • Conant K, Ahmed U, Schwartz JP, Major EO (1998a). IFN-gamma inhibits AP-1 binding activity in human brain-derived cells through a nitric oxide dependent mechanism. J Neuroimmunol 88: 39–44.

    Article  PubMed  CAS  Google Scholar 

  • Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998b). Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 95: 3117–3121.

    Article  PubMed  CAS  Google Scholar 

  • Conant K, Haughey N, Nath A, St Hillaire C, Gary DS, Pardo CA, Wahl LM, Bilak M, Milward E, Mattson MP (2002). Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase-9. J Neurochem 82: 885893.

    Article  Google Scholar 

  • Conant K, Ma M, Nath A, Major EO (1996). Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol 70: 1384–1389.

    PubMed  CAS  Google Scholar 

  • Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN (1999). Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46: 391–398.

    Article  PubMed  CAS  Google Scholar 

  • Dhawan S, Puri RK, Kumar A, Duplan H, Masson JM, Aggarwal BB (1997). Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90: 1535–1544.

    PubMed  CAS  Google Scholar 

  • Dumin JA, Dickeson SK, Stricker TP, Bhattacharyya-Pakrasi M, Roby JD, Santoro SA, Parks WC (2001). Procollagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem 276: 29368–29374.

    Article  PubMed  CAS  Google Scholar 

  • Epstein LG, Gendelman HE (1993). Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33: 429–436.

    Article  PubMed  CAS  Google Scholar 

  • Fernandez-Patron C, Radomski MW, Davidge ST (1999). Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 85: 906–911.

    PubMed  CAS  Google Scholar 

  • Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M (1998). Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin Exp Metastasis 16: 513–528.

    Article  PubMed  CAS  Google Scholar 

  • Flora G, Lee YW, Nath A, Maragos W, Hennig B, Toborek M (2002). Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. Neuromolecular Med 2: 71–85.

    Article  PubMed  CAS  Google Scholar 

  • Fowlkes JL, Enghild JJ, Suzuki K, Nagase H (1994). Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 269: 25742–25746.

    PubMed  CAS  Google Scholar 

  • Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755–762.

    Article  PubMed  CAS  Google Scholar 

  • Gottschall PE, Yu X (1995). Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64: 1513–1520.

    Article  PubMed  CAS  Google Scholar 

  • Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA (2002). S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186–1190.

    Article  PubMed  CAS  Google Scholar 

  • Hui A, Min WX, Tang J, Cruz TF (1998). Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum 41: 869–876.

    Article  PubMed  CAS  Google Scholar 

  • Ishihara T, Akiyama K, Kashihara K (1998). Enhanced AP-1 binding in brain induced by D1 and D2 agonists in methamphetamine-sensitized rats. Neuroreport 9: 3913–3917.

    Article  PubMed  CAS  Google Scholar 

  • Johnston JB, Zhang K, Silva C, Shalinsky DR, Conant K, Ni W, Corbett D, Yong VW, Power C (2001). HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol 49: 230–241.

    Article  PubMed  CAS  Google Scholar 

  • Kumar A, Dhawan S, Mukhopadhyay A, Aggarwal BB (1999). Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett 462: 140–144.

    Article  PubMed  CAS  Google Scholar 

  • Kumar A, Manna SK, Dhawan S, Aggarwal BB (1998). HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J Immunol 161: 776–781.

    PubMed  CAS  Google Scholar 

  • Lim SP, Garzino-Demo A (2000). The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites. J Virol 74: 1632–1640.

    Article  PubMed  CAS  Google Scholar 

  • Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D (2001). The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124: 1743–1753.

    Article  PubMed  CAS  Google Scholar 

  • Lorenzl S, Albers DS, Le Witt PA, Chirichigno JW, Hilgenberg SL, Cudkowicz ME, Beal MF (2003). Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J Neurol Sci 207: 71–76.

    Article  PubMed  CAS  Google Scholar 

  • Luo Y, Hattori A, Munoz J, Qin ZH, Roth GS (1999). Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. Mol Pharmacol 56: 254–264.

    PubMed  CAS  Google Scholar 

  • Ma M, Nath A (1997). Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495–2499.

    PubMed  CAS  Google Scholar 

  • Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1995). Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37: 373–380.

    Article  PubMed  CAS  Google Scholar 

  • Mayne M, Holden CP, Nath A, Geiger JD (2000). Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J Immunol 164: 6538–6542.

    PubMed  CAS  Google Scholar 

  • Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P (1997). Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 16: 2319–2332.

    Article  PubMed  CAS  Google Scholar 

  • McCawley LJ, Matrisian LM (2001). Matrix metalloproteinases: they’re not just for matrix anymore! Curr Opin Cell Biol 13: 534–540.

    Article  PubMed  CAS  Google Scholar 

  • McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM (2001). Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276: 43503–43508.

    Article  PubMed  CAS  Google Scholar 

  • Nagase H, Woessner JF, Jr (1999). Matrix metalloproteinases. J Biol Chem 274: 21491–21494.

    Article  PubMed  CAS  Google Scholar 

  • Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR (2001). Acceleration of HIV dementia with methamphetamine and cocaine. J NeuroVirol 7: 66–71.

    Article  PubMed  CAS  Google Scholar 

  • Ott M, Lovett JL, Mueller L, Verdin E (1998). Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. J Immunol 160: 2872–2880.

    PubMed  CAS  Google Scholar 

  • Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM (1999). The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. CurrBiol 9: 1441–1447.

    CAS  Google Scholar 

  • Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34: 339–350.

    Article  PubMed  CAS  Google Scholar 

  • Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS (1997). Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692–695.

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg GA (2002). Matrix metalloproteinases in neuroinflammation. Glia 39: 279–291.

    Article  PubMed  Google Scholar 

  • Rosenberg GA, Navratil M (1997). Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48: 921–926.

    PubMed  CAS  Google Scholar 

  • Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56: 257–260.

    PubMed  CAS  Google Scholar 

  • Sato T, Koike L, Miyata Y, Hirata M, Mimaki Y, Sashida Y, Yano M, Ito A (2002). Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res 62: 1025–1029.

    PubMed  CAS  Google Scholar 

  • Sawaya BE, Thatikunta P, Denisova L, Brady J, Khalili K, Amini S (1998). Regulation of TNFalpha and TGFbeta-1 gene transcription by HIV-1 Tat in CNS cells. J Neuroimmunol 87: 33–42.

    Article  PubMed  CAS  Google Scholar 

  • Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B (1996). Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A 93: 700–704.

    Article  PubMed  CAS  Google Scholar 

  • Schonbeck U, Mach F, Libby P (1998). Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161: 3340–3346.

    PubMed  CAS  Google Scholar 

  • Shapiro S, Miller A, Lahat N, Sobel E, Lerner A (2003). Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis. J Neurol Sci 206: 43–48.

    Article  PubMed  CAS  Google Scholar 

  • Spencer DC, Price RW (1992). Human immunodeficiency virus and the central nervous system. Annu Rev Microbiol 46: 655–693.

    Article  PubMed  CAS  Google Scholar 

  • Stricker TP, Dumin JA, Dickeson SK, Chung L, Nagase H, Parks WC, Santoro SA (2001). Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J Biol Chem 276: 29375–29381.

    Article  PubMed  CAS  Google Scholar 

  • Sundstrom JB, Mosunjac M, Martinson DE, Bostik P, Donahoe RM, Gravanis MB, Ansari AA (2001). Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases. AIDS Res Hum Retroviruses 17: 1605–1614.

    Article  PubMed  CAS  Google Scholar 

  • Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G (2000). Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96: 2673–2681.

    PubMed  Google Scholar 

  • Vos CM, Sjulson L, Nath A, McArthur JC, Pardo CA, Rothstein J, Conant K (2000). Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures. Exp Neurol 163: 324–330.

    Article  PubMed  CAS  Google Scholar 

  • Wang Y, Chou J, Jeng CH, Morales M, Wang JY (2000). Chronic methamphetamine exposure decreases high affinity uptake function in norepinephrine afferents in the cerebellar cortex: an electrophysiological and electrochemical study. Neuropharmacology 39: 2112–2123.

    Article  PubMed  CAS  Google Scholar 

  • Woessner JF, Nagase H (2000). Matrix metalloproteinases and TIMPs. Oxford; New York: Oxford University Press.

    Google Scholar 

  • Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT (2000). Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 97: 11466–11471.

    Article  PubMed  CAS  Google Scholar 

  • Yebra M, Goretzki L, Pfeifer M, Mueller BM (1999). Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp Cell Res 250: 231–240.

    Article  PubMed  CAS  Google Scholar 

  • Yu Q, Stamenkovic I (1999). Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13: 35–48.

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Looney D, Taub D, Chang SL, Way D, Witte MH, Graves MC, Fiala M (1998). Cocaine opens the blood-brain barrier to HIV-1 invasion. J Neurovirol 4: 619–626.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA

    Katherine Conant, Coryse St Hillaire, Caroline Anderson, David Galey, Jessica Wang & Avindra Nath

Authors
  1. Katherine Conant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Coryse St Hillaire
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caroline Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Galey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jessica Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Avindra Nath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katherine Conant.

Additional information

This work was supported by the National Institute on Drug Abuse (13820).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conant, K., St Hillaire, C., Anderson, C. et al. Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. Journal of NeuroVirology 10, 21–28 (2004). https://doi.org/10.1080/13550280490261699

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280490261699

Keywords

Search

Navigation